Ledger.Open graph →
SEC Form D · filed September 15, 2020

RECURSION PHARMACEUTICALS, INC

Offering
$235.5M
Sold
$235.5M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
SALT LAKE CITY, UT
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (27)

R. M. Chavez · SALT LAKE CITY, UTDirectorBlake C. Borgeson · SALT LAKE CITY, UTDirectorChristopher C. Gibson · SALT LAKE CITY, UTExec · Director · PromoterMichael M. Secora · SALT LAKE CITY, UTExec · PromoterDean C. Li · SALT LAKE CITY, UTDirectorZachary C. Bogue · PALO ALTO, CADirectorTerry-Ann C. Burrell · SALT LAKE CITY, UTDirectorZavain P. Dar · MENLO PARK, CADirectorRobert C. Hershberg · SALT LAKE CITY, UTDirectorKyu Jo · New York, NYDirectorJonathan S. Katz · New York, NYDirectorWilliam R. Cowen · Needham, MAExec · Director · PromoterGrant P. Gund · Needham, MADirectorRichard Ruffer · Wilmington, DEDirectorGonzalo Trenosky · Fort Mill, SCDirectorChrista Dorrego · New York, NYDirectorAshish Dodia · Wilmington, DEDirectorLeonard P. Hedge · Needham, MAExec · PromoterVasudev Kulkarni · New York, NYDirectorSteve M. Ritchie · Louisville, KYDirectorPaul Conley · San Diego, CADirectorChris Neary · San Diego, CADirectorNicolas Barthelemy · San Diego, CADirectorJose Morachis · SAN DIEGO, CADirectorAthena Demos · Van Nuys, CAExec · Director · PromoterMatthew B. Popoli · Boston, MADirectorPeter Diamandis · Naples, FLExec · Promoter

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗